Literature DB >> 11121073

Deletion of tyrosine hydroxylase gene reveals functional interdependence of adrenocortical and chromaffin cell system in vivo.

S R Bornstein1, H Tian, A Haidan, A Böttner, N Hiroi, G Eisenhofer, S M McCann, G P Chrousos, S Roffler-Tarlov.   

Abstract

Catecholamines are produced in the medulla of the adrenal gland and may participate in the intraglandular regulation of its cortex. We analyzed the adrenal structure and function of albino tyrosine hydroxylase-null (TH-null) mice that are deficient in adrenal catecholamine production. Adrenal catecholamines were markedly reduced, and catecholamine histofluorescence was abrogated in 15-day-old TH-null mice. Chromaffin cell structure was strikingly altered at the ultrastructural level with a depletion of chromaffin vesicles and an increase in rough endoplasmic reticulum compared with wild-type mice. Remaining chromaffin vesicles lined up proximally to the cell membrane in preparation for exocytosis providing a "string-of-pearls" appearance. There was a 5-fold increase in the expression of proenkephalin mRNA (502.8 +/- 142% vs. 100 +/- 17.5%, P = 0.016) and a 2-fold increase in the expression of neuropeptide Y (213.4 +/- 41.2% vs. 100 +/- 59.9%, P = 0.014) in the TH-null animals as determined by quantitative TaqMan (Perkin-Elmer) PCR. Accordingly, immunofluorescence for met-enkephalin and neuropeptide tyrosine in these animals was strongly enhanced. The expression of phenylethanolamine N-methyl transferase and chromogranin B mRNA was similar in TH-null and wild-type mice. In TH-null mice, adrenocortical cells were characterized by an increase in liposomes and by tubular mitochondria with reduced internal membranes, suggesting a hypofunctional state of these steroid-producing cells. In accordance with these findings, plasma corticosterone levels were decreased. Plasma ACTH levels were not significantly different in TH-null mice. In conclusion, both the adrenomedullary and adrenocortical systems demonstrate structural and functional changes in catecholamine-deficient TH-null mice, underscoring the great importance of the functional interdependence of these systems in vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11121073      PMCID: PMC18989          DOI: 10.1073/pnas.97.26.14742

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  56 in total

1.  Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase.

Authors:  G Eisenhofer; D S Goldstein; R Stull; H R Keiser; T Sunderland; D L Murphy; I J Kopin
Journal:  Clin Chem       Date:  1986-11       Impact factor: 8.327

Review 2.  The regulation of enkephalin levels in adrenomedullary cells and its relation to chromaffin vesicle biogenesis and functional plasticity.

Authors:  O H Viveros; E J Diliberto; J H Hong; J S Kizer; C D Unsworth; T Kanamatsu
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

Review 3.  Posttranslational processing of proenkephalins and chromogranins/secretogranins.

Authors:  L Dillen; B Miserez; M Claeys; D Aunis; W De Potter
Journal:  Neurochem Int       Date:  1993-04       Impact factor: 3.921

4.  Developmental regulation of leucine-enkephalin expression in adrenal chromaffin cells by glucocorticoids and innervation.

Authors:  P D Henion; S C Landis
Journal:  J Neurosci       Date:  1992-10       Impact factor: 6.167

5.  Regulation of expression of dopamine beta-hydroxylase in PC12 cells by glucocorticoids and cyclic AMP analogues.

Authors:  A McMahon; E L Sabban
Journal:  J Neurochem       Date:  1992-12       Impact factor: 5.372

6.  Regulation of tyrosine hydroxylase gene transcription rate and tyrosine hydroxylase mRNA stability by cyclic AMP and glucocorticoid.

Authors:  L H Fossom; C R Sterling; A W Tank
Journal:  Mol Pharmacol       Date:  1992-11       Impact factor: 4.436

7.  Regulation of adrenal steroidogenesis by adrenaline: expression of cytochrome P450 genes.

Authors:  H Güse-Behling; M Ehrhart-Bornstein; S R Bornstein; M R Waterman; W A Scherbaum; G Adler
Journal:  J Endocrinol       Date:  1992-11       Impact factor: 4.286

8.  Stress-induced norepinephrine release in the paraventricular nucleus of rats with brainstem hemisections: a microdialysis study.

Authors:  K Pacák; M Palkovits; R Kvetnansky; I J Kopin; D S Goldstein
Journal:  Neuroendocrinology       Date:  1993-08       Impact factor: 4.914

9.  Structure and dynamics of adrenal mitochondria following stimulation with corticotropin releasing hormone.

Authors:  S R Bornstein; M Ehrhart-Bornstein; H Güse-Behling; W A Scherbaum
Journal:  Anat Rec       Date:  1992-10

10.  Bovine chromaffin granules: immunological studies with antisera against neuropeptide Y, [Met]enkephalin and bombesin.

Authors:  R Fischer-Colbrie; J Diez-Guerra; P C Emson; H Winkler
Journal:  Neuroscience       Date:  1986-05       Impact factor: 3.590

View more
  13 in total

Review 1.  Role of neurotransmitters and neuropeptides in the regulation of the adrenal cortex.

Authors:  C Delarue; V Contesse; S Lenglet; F Sicard; V Perraudin; H Lefebvre; M Kodjo; F Leboulenger; L Yon; N Gallo-Payet; H Vaudry
Journal:  Rev Endocr Metab Disord       Date:  2001-08       Impact factor: 6.514

Review 2.  Lessons learned from gene targeting and transgenesis for adrenal physiology and disease.

Authors:  A Böttner; S R Bornstein
Journal:  Rev Endocr Metab Disord       Date:  2001-08       Impact factor: 6.514

3.  Tyrosine hydroxylase, chromogranin A, and steroidogenic acute regulator as markers for successful separation of human adrenal medulla.

Authors:  Stephanie M J Fliedner; Jan Breza; Richard Kvetnansky; James F Powers; Arthur S Tischler; Robert Wesley; Maria Merino; Hendrik Lehnert; Karel Pacak
Journal:  Cell Tissue Res       Date:  2010-04-30       Impact factor: 5.249

4.  Deletion of the neuropeptide Y (NPY) Y1 receptor gene reveals a regulatory role of NPY on catecholamine synthesis and secretion.

Authors:  Cláudia Cavadas; Daniel Céfai; Joana Rosmaninho-Salgado; Maria Augusta Vieira-Coelho; Eduardo Moura; Nathalie Busso; Thierry Pedrazzini; Daniela Grand; Samuel Rotman; Bernard Waeber; Jean-François Aubert; Eric Grouzmann
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-23       Impact factor: 11.205

5.  Hypertension from targeted ablation of chromogranin A can be rescued by the human ortholog.

Authors:  Nitish R Mahapatra; Daniel T O'Connor; Sucheta M Vaingankar; Amiya P Sinha Hikim; Manjula Mahata; Saugata Ray; Eugenie Staite; Hongjiang Wu; Yusu Gu; Nancy Dalton; Brian P Kennedy; Michael G Ziegler; John Ross; Sushil K Mahata
Journal:  J Clin Invest       Date:  2005-07       Impact factor: 14.808

Review 6.  Cortical-chromaffin cell interactions in the adrenal gland.

Authors:  Sven Schinner; Stefan R Bornstein
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

7.  Alpha2-adrenoceptor subtypes involved in the regulation of catecholamine release from the adrenal medulla of mice.

Authors:  E Moura; J Afonso; L Hein; M A Vieira-Coelho
Journal:  Br J Pharmacol       Date:  2006-10-30       Impact factor: 8.739

8.  Blood sampling methodology is crucial for precise measurement of plasma catecholamines concentrations in mice.

Authors:  Eric Grouzmann; Claudia Cavadas; Daniela Grand; Martine Moratel; Jean-François Aubert; Hans R Brunner; Lucia Mazzolai
Journal:  Pflugers Arch       Date:  2003-08-05       Impact factor: 3.657

9.  Functional programming of the autonomic nervous system by early life immune exposure: implications for anxiety.

Authors:  Luba Sominsky; Erin A Fuller; Evgeny Bondarenko; Lin Kooi Ong; Lee Averell; Eugene Nalivaiko; Peter R Dunkley; Phillip W Dickson; Deborah M Hodgson
Journal:  PLoS One       Date:  2013-03-06       Impact factor: 3.240

10.  Transgenic mice expressing constitutive active MAPKAPK5 display gender-dependent differences in exploration and activity.

Authors:  Nancy Gerits; Werner Van Belle; Ugo Moens
Journal:  Behav Brain Funct       Date:  2007-11-12       Impact factor: 3.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.